Altre lingue Praxis Precision Medicines, Inc.

Azioni

PRAX

US74006W2070

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
54,8 ^USD	+3,63%		+16,87%	+145,96%

08/04	PRAXIS PRECISION MEDICINES, INC. : per Wedbush il titolo è Neutral	ZM
28/03	Praxis Precision Medicines prezza un'offerta pubblica di 200 milioni di dollari	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Praxis Precision Medicines : April 2024 Corporate Presentation	23/04
PRAXIS PRECISION MEDICINES TO PRESENT ON ULIXACALTAMIDE AT THE AMERICAN ACADEMY OF NEUROLOGY 2024 ANNUAL MEETING	15/04
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting	12/04
Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Certain Restricted Stock Units of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Praxis Precision Medicines to Participate in Upcoming April Conferences	05/04
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/04
Praxis Precision Medicines Prices $200 Million Public Offering	28/03
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering	28/03
Praxis Precision Medicines Plans Public Equity Offering	27/03
Praxis Precision Medicines, Inc. Announces Proposed Public Offering	27/03
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients	26/03
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response Achieving 100% Response in Treated Patients	26/03
Praxis Precision Medicines to Host PRAX-628 Program Update	25/03
Praxis Precision Medicines Files $750 Million Mixed-Securities Shelf Registration	05/03
Praxis Precision Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Praxis Precision Medicines : March 2024 Corporate Presentation	05/03
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	05/03
Praxis Precision Medicines, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Praxis Precision Medicines, Inc.

Azioni

PRAX

US74006W2070

Altre lingue

Filtri